
Dr. Timothy Ellis-Caleo is a physician specializing in Hematology and Oncology with a focus on Thoracic Oncology. He is currently a Fellow in Medicine at Stanford University, actively involved in clinical care and research related to pulmonary and thoracic cancers. His academic journey began with a degree in Physics from Washington University in St. Louis, followed by his medical degree from the David Geffen School of Medicine at UCLA. He completed his residency and fellowship training at Stanford, where he now contributes to advancing cancer treatment through both clinical practice and research. His research interests include the molecular and clinical characterization of pulmonary tumors, with a particular emphasis on immunotherapy and targeted cellular therapies. Dr. Ellis-Caleo has authored multiple publications on the integration of molecular diagnostics and personalized treatment approaches in thoracic cancers. His work aims to improve outcomes for patients with lung and other thoracic malignancies by exploring innovative therapeutic strategies and understanding tumor biology at a deeper level. Recognized for his dedication to both patient care and scientific discovery, Dr. Ellis-Caleo is committed to translating research findings into clinical applications that enhance treatment efficacy and patient quality of life. His contributions to the field of thoracic oncology continue to influence emerging therapies and shape future research directions in cancer medicine.
Fellow in Medicine - Hematology
2019 – present
Medical School
2019
Residency
Fellowship